Kimia Biosciences Ltd

Kimia Bioscien. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kimia Biosciences Ltd

₹ 32.2 -0.62%
19 Jun - close price
kimiabiosciences.com BSE: 530313
About

Incorporated in 1993, Kimia Biosciences
Ltd is in the business of manufacturing
and sale pharmaceutical products[1]

Key Points

Business Verticals:[1]
a) Active Pharmaceutical Ingredients
b) Commercial KSMs, Intermediates & Reagents
c) Upcoming CRAM, CDMO, CRO services

Website BSE
  • Market Cap ₹ 152 Cr.
  • Current Price ₹ 32.2
  • High / Low ₹ 86.8 / 23.2
  • Stock P/E 20.5
  • Book Value ₹ 3.75
  • Dividend Yield 0.00 %
  • ROCE 25.1 %
  • ROE 53.7 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 53.6%

Cons

  • Stock is trading at 8.58 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -2.84% over past five years.
  • Tax rate seems low

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
22.66 24.23 24.20 26.14 30.30 22.40 28.18 30.10 38.24 23.58 34.00 30.10 27.20
28.02 25.87 26.16 27.19 26.14 18.69 24.81 25.10 30.06 21.05 31.48 23.54 24.54
Operating Profit -5.36 -1.64 -1.96 -1.05 4.16 3.71 3.37 5.00 8.18 2.53 2.52 6.56 2.66
OPM % -23.65% -6.77% -8.10% -4.02% 13.73% 16.56% 11.96% 16.61% 21.39% 10.73% 7.41% 21.79% 9.78%
-0.69 0.13 0.64 0.58 0.30 0.08 0.37 0.42 0.44 0.85 -0.33 0.10 1.01
Interest 1.26 1.28 1.12 1.31 1.34 1.11 1.04 1.01 1.40 1.75 0.27 0.75 0.75
Depreciation 0.87 0.83 0.82 0.82 0.82 0.90 0.79 0.82 0.88 0.94 0.97 0.85 1.16
Profit before tax -8.18 -3.62 -3.26 -2.60 2.30 1.78 1.91 3.59 6.34 0.69 0.95 5.06 1.76
Tax % -24.57% -25.14% -25.15% -25.00% 22.17% 19.66% 15.71% -27.30% 68.61% 13.04% -7.37% -7.71% 78.98%
-6.17 -2.71 -2.44 -1.95 1.80 1.44 1.61 4.57 1.99 0.60 1.02 5.44 0.37
EPS in Rs -1.30 -0.57 -0.52 -0.41 0.38 0.30 0.34 0.97 0.42 0.13 0.22 1.15 0.08
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
2 0 1 76 94 106 133 125 129 105 119 115
4 4 2 74 88 102 124 124 133 105 99 101
Operating Profit -2 -3 -1 2 6 4 8 1 -5 -0 20 14
OPM % -110% -1,779% -56% 3% 6% 4% 6% 0% -4% -0% 17% 12%
1 0 0 1 1 1 2 1 0 2 1 2
Interest 0 1 0 1 2 3 3 4 4 5 5 4
Depreciation 0 0 0 1 1 2 2 3 3 3 3 4
Profit before tax -2 -4 -1 2 4 1 6 -5 -12 -7 14 8
Tax % 1% 0% -8% -4% -1% -13% 8% -26% -25% -26% 29% 12%
-2 -4 -1 2 4 1 5 -4 -9 -5 10 7
EPS in Rs -2.30 -5.48 -1.26 2.26 2.64 0.30 1.08 -0.78 -1.98 -1.12 2.03 1.57
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 90%
5 Years: -3%
3 Years: -4%
TTM: -3%
Compounded Profit Growth
10 Years: 14%
5 Years: 8%
3 Years: 43%
TTM: -23%
Stock Price CAGR
10 Years: 20%
5 Years: -8%
3 Years: -2%
1 Year: -32%
Return on Equity
10 Years: %
5 Years: -1%
3 Years: 54%
Last Year: 54%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 7 7 7 1 1 5 5 5 5 5 5 5
Reserves -7 -11 -12 0 4 9 14 10 1 -4 5 13
1 7 14 34 31 34 45 41 53 44 33 35
4 1 3 22 29 38 43 54 63 56 68 51
Total Liabilities 5 4 12 58 65 86 107 109 121 100 111 103
3 3 7 13 16 18 28 35 34 32 33 37
CWIP 0 0 3 2 2 6 6 0 1 1 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
1 1 2 43 48 62 72 74 87 68 78 66
Total Assets 5 4 12 58 65 86 107 109 121 100 111 103

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 -6 -1 -7 -3 0 6 8 -7 15 21 11
0 -0 -6 -2 -2 -9 -14 -1 -3 -1 -5 -8
-0 6 7 10 4 8 8 -8 10 -13 -17 -3
Net Cash Flow -0 0 0 0 -0 0 0 -0 -0 -0 0 0
Free Cash Flow 0 -6 -7 -10 -5 -9 -8 6 -10 13 17 3
CFO/OP -2% 177% 85% -287% -45% 5% 71% 1,281% 136% -3,021% 105% 76%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 56 173 20 141 113 128 115 88 87 96 113 93
Inventory Days 50 319 615 59 83 92 89 146 183 149 178 137
Days Payable 667 91 511 120 91 121 116 159 177 194 260 220
Cash Conversion Cycle -560 401 124 80 105 100 88 76 93 51 31 10
Working Capital Days -530 -173 -1,358 48 62 73 53 31 16 -30 -22 5
ROCE % -127% -188% -10% 10% 16% 9% 16% -2% -12% -4% 42% 25%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtors Turnover Ratio
times

Log in to view insights

Please log in to see hidden values.

Login
Number of Permanent Employees
count
Total R&D Expenditure
INR Lakhs
Number of Patents Filed
count
Commercialized Products
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
74.94% 74.94% 74.94% 74.94% 74.94% 74.94% 74.94% 74.94% 74.94% 74.94% 74.94% 74.94%
0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38%
24.68% 24.67% 24.66% 24.67% 24.68% 24.67% 24.68% 24.67% 24.68% 24.68% 24.68% 24.68%
No. of Shareholders 12,14712,11812,06312,11012,02312,17912,23112,27812,20012,61612,75112,775

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports